iA Global Asset Management Inc.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1969566
Quebec, A8
Position in AMLX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,455,996
+$1,219,471 QoQ
Shares Held
303,786
-0.3% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#51
of 207 holders
Holding Since
Mar 2026
2 quarters on record
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $25,098,205 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
341,622 | $11,574,153 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
303,786 | $5,455,996 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
522,992 | $5,141,011 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
9,166 | $1,544,837 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,551 | $1,382,208 |
All Filings in AMLX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,455,996 | 303,786 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,236,525 | 304,786 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||